InMode Ltd (INMD): Kapitalisasi marang pendapatan
The P/S ratio dynamics for InMode Ltd. (INMD) reflect the current market trend, where the parameter value equals 2.00. The high prestige of Israeli minimally invasive systems ensures physician loyalty. Meanwhile, the implementation of ESG standards minimizes waste during device assembly. However, geopolitical tensions and logistics disruptions limit the expansion of high-tech equipment into foreign markets, creating risks for expansion rates.
Rincian analitis perusahaan InMode Corp (INMD)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal InMode Ltd.|INMD - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas InMode MD|INMD - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku InMode Corp|INMD - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan InMode|Rasio jangkoan perantara inmodemd.com
- data bathi lan kelipatan valuasi:
INMD - Bathi resik|Bathi resik sing dikarepake InMode Ltd.|INMD - Rasio rega marang bathi|Pangali forward rega marang bathi InMode Ltd|INMD - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA InMode Corp|INMD - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan InMode|INMD - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan inmodemd.com|INMD - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep InMode Ltd.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:INMD inmodemd.com
The P/S multiple relates current market capitalization to annual sales volume, allowing for the determination of the premium paid per unit of revenue. By analyzing the price-to-sales multiple, an investor assesses the monetization efficiency of InMode Ltd. medical technologies, which directly depends on consumer demand for aesthetic surgery and the successful implementation of equipment into physicians' clinical practice.
Pesaing InMode Ltd.
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|Picard Medical Corp (PMI) - Koefisien rega marang pendapatan|Multiplikator P/S SRDX|Kapitalisasi marang pendapatan Eversense SENS|Multiplikator P/S NPCE (NeuroPace, Inc.)|Multiplikator P/S Tactile Systems Technology, Inc. TCMD|SNWV - Rasio rega marang pendapatan|OM: Rasio rega marang pendapatan|ELMD (smartvest.com) - Kapitalisasi marang pendapatan|LENSAR Inc - Rasio kapitalisasi pasar marang pendapatan|RCEL (AVITA Medical, Inc.) - Multiplikator P/S|Rega marang dodolan Profound Medical Corporation PROF|Rasio rega marang pendapatan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Multiplikator rega marang pendapatan|Apyx Medical Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S IceCure Medical Ltd. ICCM|Pulmonx Corp. - Multiplikator P/S|Koefisien rega marang pendapatan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTS (Sensus Healthcare Inc)|Rasio rega marang pendapatan Zynex Inc|Kapitalisasi marang pendapatan electroCore Medical (ECOR)|Multiplikator P/S RBOT|IINN - Rega marang dodolan|Rasio rega marang pendapatan SeaStar Medical ICU|IRIX: Rasio kapitalisasi marang pendapatan|INBS: Kapitalisasi marang pendapatan|Beyond Air, Inc. - Kapitalisasi marang volume dodolan|PFSA: Multiplikator P/S|SSKN - Koefisien rega marang pendapatan|Rasio rega marang pendapatan GlucoTrack, Inc.|Rasio kapitalisasi marang pendapatan NAOV (nanovibronix.com)|Rasio rega marang pendapatan Venus Concept Corp (VERO)|Kapitalisasi marang pendapatan Nuwellis Corp NUWE|Rasio rega marang pendapatan Aethlon Medical AEMD|Asensus Surgical Inc (ASXC) - Rega marang dodolan|Avinger - Multiplikator P/S|BSGM (BioSig) - Rasio kapitalisasi marang pendapatan|CUTR: Multiplikator P/S|Rega marang dodolan Know Labs Corporation (KNW)|Kapitalisasi marang pendapatan NARI|NVRO: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan ReShape Lifesciences (RSLS)|Rasio rega marang pendapatan SILK (Silk Road Medical, Inc.)
